Sofie-yasmin Hassan

University Street 1
Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Stemness and Survival: CD117+/CD133+ Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal Melanoma.

Stemness and Survival: CD117+/CD133+ Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal Melanoma.

Journal: Cells

Published: January 25, 2026

Mucosal Melanoma: Mechanisms of Its Etiology, Progression, Resistance and Therapy.

Mucosal Melanoma: Mechanisms of Its Etiology, Progression, Resistance and Therapy.

Journal: Cells

Published: October 18, 2025

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.

Journal: Cancers

Published: May 29, 2024

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.

Journal: Cancers

Published: December 05, 2023

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.

Journal: Cells

Published: November 29, 2023

Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment.

Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment.

Journal: Cancers

Published: May 07, 2023

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways.

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways.

Journal: International journal of molecular sciences

Published: February 16, 2023

Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways.

Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways.

Journal: Oncogene

Published: July 26, 2019

MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.

MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: May 27, 2018

[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways.

[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways.

Journal: International journal of oncology

Published: November 07, 2017

Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways.

Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways.

Journal: International journal of oncology

Published: November 07, 2017

Cancer stem cell as therapeutic target for melanoma treatment.

Cancer stem cell as therapeutic target for melanoma treatment.

Journal: Histology and histopathology

Published: June 16, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026